Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhofanib (tofacitinib) for treatment of lichen planopilaris
IRCT20200107046041N2Phase 3Completed
- Sponsor
- NanoAlvand
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tofacitinib in lichen planopilaris (LPP), sponsored by NanoAlvand. Started Aug 2020; status: completed.
02
Drugs
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on IRCT20200107046041N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200107046041N2.